A191901
OPEN TO ACCRUAL
Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions
MA39
OPEN TO ACCRUAL
Tailor RT: Low Risk Node Positive Breast Cancer Trial
NRGBR009
OPEN TO ACCRUAL
Trial Evaluating Addition of Adjuvant Chemo to Ovarian Function Suppression + Endocrine Therapy
UW21002
OPEN TO ACCRUAL
PII Trial of ctDNA-Guided 2nd line Adjuvant Therapy for High Risk, Stage II-III, ER+ HER2- BC (DARE)